Compounds > mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin
Page last updated: 2024-09-04

mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin and malondialdehyde

mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin has been researched along with malondialdehyde in 1 studies

Compound Research Comparison

Studies
(mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin)		Trials
(mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin)		Recent Studies (post-2010)
(mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin)		Studies
(malondialdehyde)		Trials
(malondialdehyde)		Recent Studies (post-2010) (malondialdehyde)
6904227,8491,40513,922

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gupta, S; Sharma, SS1

Other Studies

1 other study(ies) available for mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin and malondialdehyde

ArticleYear
Neuroprotective effect of MnTMPyP, a superoxide dismutase/catalase mimetic in global cerebral ischemia is mediated through reduction of oxidative stress and DNA fragmentation.
    European journal of pharmacology, 2007, Apr-30, Volume: 561, Issue:1-3

    Topics: Animals; Brain Ischemia; Catalase; Disease Models, Animal; DNA Fragmentation; Gerbillinae; Hippocampus; In Situ Nick-End Labeling; Lipid Peroxidation; Male; Malondialdehyde; Metalloporphyrins; Motor Activity; Neurons; Neuroprotective Agents; Oxidative Stress; Pyramidal Cells; Superoxide Dismutase

2007